Lv1
50 积分 2024-07-24 加入
185 (PB173): The novel peptide drug conjugate AVA6103 is a FAP-enabled preCISION™ medicine which targets Topoisomerase I to the tumor microenvironment via FAP cleavage
7个月前
已完结
The novel peptide drug conjugate AVA6103 is a FAP-enabled preCISION™ medicine which targets Topoisomerase I to the tumor microenvironment via FAP cleavage
7个月前
已关闭